How does 2-fluoro-2-deoxyglucose help in detecting tumors using imaging technology?

It binds to tumor-specific antigens, making them visible in imaging scans.

It inhibits glycolysis in cancer cells, causing them to shrink and become visible in scans.

It is metabolized by cancer cells, producing a fluorescent compound detectable by imaging.

It accumulates in cancer cells due to high glycolytic activity, allowing imaging technology to detect the radio-labeled fluorine.